TrialCancer medicine2020

A prospective multicenter phase II study on the efficacy and safety of dasatinib in the treatment of metastatic gastrointestinal stromal tumors failed by imatinib and sunitinib and analysis of NGS in peripheral blood.

Ye Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.